Camlin Fine Sciences Limited share price
NSE: CAMLINFINE · ISIN INE052I01032
Key numbers
- Market cap
- ₹ 1,869 Cr
- Current price
- ₹ 97.30
- 52-week high / low
- ₹ 218 / 96
- Stock P/E
- 317.9
- Book value
- ₹ 54.2
- Dividend yield
- 0.00%
- ROCE
- 2.0%
- ROE
- 2.8%
- Debt to equity
- 0.69
- Sales growth (3 yrs)
- 0.8%
- Profit growth (3 yrs)
- -21.8%
- 1-year return
- -57.0%
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its products under the Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 408 | 460 | 457 | 425 | 520 |
| Operating profit | 20 | 36 | 145 | 21 | 9 |
| Net profit | -10 | -14 | -36 | 88 | -32 |
| EPS (₹) | -0.53 | -0.77 | -1.91 | 4.59 | -1.65 |
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.